The risk of breast cancer has long been a concern of the doctors who prescribe and women who use hormone replacement therapy. How much? and for how long? are two of the most commonly asked questions. It has been hard to reach a definitive conclusion as to the degree of risk involved. Hormone Replacement Therapy and Breast Cancer examines the latest data in the field and provides a balanced clinical assessment of the risk based on observations from many clinical trials. It discusses different approaches to therapy, maximum desirable duration of therapy, and the risk/benefit ratio for different kinds of patients.